Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Karaboyas

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2020
Community Racial Composition and Hospitalization Among Patients Receiving In-Center HemodialysisLadan Golestaneh, Kerri L Cavanaugh, Yungtai Lo, et al.
Clinical Kidney Journal|June 18, 2024
Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort studyCorey Toye, Manish M Sood, Ranjeeta Mallick, et al.
Kidney Medicine|April 23, 2026
Gabapentin Utilization and Adverse Effects Among US Hemodialysis Patients Diagnosed With Pruritus or Neuropathic PainClaudio Rigatto, Ting Lu, Thilo Schaufler, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2024
Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?Manfred Hecking, Angelo Karaboyas, Simon Krenn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2021
Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis PatientsAngelo Karaboyas, Daniel Muenz, Douglas S Fuller, et al.
Kidney International Reports|June 14, 2019
Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions-A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)Heide A Stirnadel-Farrant, Angelo Karaboyas, Borut Cizman, et al.
BMC Nephrology|November 27, 2025
Chronic kidney disease associated pruritus and healthcare resource utilization in European hemodialysis patients: results from an electronic patient-reported outcome surveyJames Fotheringham, Charlotte Tu, Ronald L Pisoni, et al.
Kidney Medicine|May 31, 2022
Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World EffectivenessAngelo Karaboyas, Daniel Muenz, Yunji Hwang, et al.
Kidney International Reports|January 16, 2026
Longitudinal Trajectories of CKD-Associated PruritusMarc G Vervloet, Charlotte Tu, Sammantha Fuller, et al.
BMC Nephrology|September 5, 2023
Receiving hemodialysis in Hispanic ethnic dense communities is associated with better adherence and outcomes among young patients: a retrospective analysis of the Dialysis Outcomes and Practice Patterns StudyAyana K April-Sanders, Angelo Karaboyas, Milagros Yunes, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2020
Community Racial Composition and Hospitalization Among Patients Receiving In-Center HemodialysisLadan Golestaneh, Kerri L Cavanaugh, Yungtai Lo, et al.
Clinical Kidney Journal|June 18, 2024
Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort studyCorey Toye, Manish M Sood, Ranjeeta Mallick, et al.
Kidney Medicine|April 23, 2026
Gabapentin Utilization and Adverse Effects Among US Hemodialysis Patients Diagnosed With Pruritus or Neuropathic PainClaudio Rigatto, Ting Lu, Thilo Schaufler, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2024
Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?Manfred Hecking, Angelo Karaboyas, Simon Krenn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2021
Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis PatientsAngelo Karaboyas, Daniel Muenz, Douglas S Fuller, et al.
Kidney International Reports|June 14, 2019
Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions-A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)Heide A Stirnadel-Farrant, Angelo Karaboyas, Borut Cizman, et al.
BMC Nephrology|November 27, 2025
Chronic kidney disease associated pruritus and healthcare resource utilization in European hemodialysis patients: results from an electronic patient-reported outcome surveyJames Fotheringham, Charlotte Tu, Ronald L Pisoni, et al.
Kidney Medicine|May 31, 2022
Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World EffectivenessAngelo Karaboyas, Daniel Muenz, Yunji Hwang, et al.
Kidney International Reports|January 16, 2026
Longitudinal Trajectories of CKD-Associated PruritusMarc G Vervloet, Charlotte Tu, Sammantha Fuller, et al.
BMC Nephrology|September 5, 2023
Receiving hemodialysis in Hispanic ethnic dense communities is associated with better adherence and outcomes among young patients: a retrospective analysis of the Dialysis Outcomes and Practice Patterns StudyAyana K April-Sanders, Angelo Karaboyas, Milagros Yunes, et al.
Pageof 9